260
Z.-L. Zhou et al.
LETTER
1598. (c) Fan, X. S.; He, Y.; Zhang, X. Y.; Guo, S. H.;
Wang, Y. Y. Tetrahedron 2011, 67, 6369. (d) Mu, X. J.;
Zou, J. P.; Zeng, R. S.; Wu, J. C. Tetrahedron Lett. 2005, 46,
4345. (e) Zhu, Y. P.; Jia, F. C.; Liu, M. C.; Wu, A. X. Org.
Lett. 2012, 14, 4414. (f) Yang, Z. Y.; Chen, X.; Wang, S. Z.;
Liu, J. D.; Xie, K.; Wang, A. W.; Tan, Z. J. Org. Chem.
2012, 77, 7086. (g) Fan, X. S.; He, Y.; Wang, Y. Y.; Xue, Z.
K.; Zhang, X. Y.; Wang, J. J. Tetrahedron Lett. 2011, 52,
899.
Supporting Information for this article is available online at
m
iotSrat
ungIifoop
r
t
References and Notes
(1) (a) Dondoni, A. Comprehensive Heterocyclic Chemistry II;
Vol. 3; Shinkai, I. E., Ed.; Pergamon: Glasgow, 1996, 373.
(b) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev.
2003, 103, 893.
(2) (a) Yao, S.; Schafer-Hales, K. J.; Belfield, K. D. Org. Lett.
2007, 9, 5645. (b) Rodionov, V. O.; Presolski, S. I.;
Gardinier, S.; Lim, Y. H.; Finn, M. G. J. Am. Chem. Soc.
2007, 129, 12696. (c) Zajac, M.; Hrobriák, P.; Magdolen, P.;
Foltínová, P.; Zahradník, P. Tetrahedron 2008, 64, 10605.
(d) Sahu, P. K.; Sahu, P. K.; Gupta, S. K.; Thavaselvam, D.;
Agarwal, D. D. Eur. J. Med. Chem. 2012, 54, 366.
(7) Dieter, R. K. Tetrahedron 1999, 55, 4177.
(8) Boga, C.; Stengel, R.; Abdayem, R.; Vecchio, E. D.; Forlani,
L.; Todesco, P. E. J. Org. Chem. 2004, 69, 8903.
(9) Fan, X. S.; He, Y.; Guo, S. H.; Zhang, X. Y. Aust. J. Chem.
2011, 64, 1578.
(10) (a) Zhu, Y. P.; Lian, Mi.; Jia, F. C.; Liu, M. C.; Yuan, J. J.;
Gao, Q. H.; Wu, A. X. Chem. Commun. 2012, 48, 9086.
(b) Gao, Q. H.; Wu, X.; Jia, F. C.; Liu, M. C.; Zhu, Y. P.;
Cai, Q.; Wu, A. X. J. Org. Chem. 2013, 78, 2792.
(11) Fan, X. S.; He, Y.; Zhang, X. Y.; Guo, S. H.; Wang, Y. Y.
Tetrahedron 2011, 67, 6369.
(e) Christodoulou, M. S.; Colombo, F.; Passarella, D.;
Leronimo, G.; Zuco, V.; Cesare, D. M.; Zunino, F. Bioorg.
Med. Chem. 2011, 19, 1649. (f) Bradshaw, T. D.; Westwell,
A. D. Curr. Med. Chem. 2004, 11, 1009.
(12) Recently, Srogl reported a similar Cu(I) complex-catalyzed
methodology of synthesis of 2-acylbenzothiazoles under
acidic conditions, see: Hyvl, J.; Srogl, J. Eur. J. Org. Chem.
2010, 2849.
(3) (a) Chekler, E. L. P.; Katoch-Rouse, R.; Kiselyov, A. S.;
Sherman, D.; Ouyang, X. H.; Kim, K.; Wang, Y.; Hadari, Y.
R.; Doody, J. F. Bioorg. Med. Chem. Lett. 2008, 18, 4344.
(b) Zhang, X.; Wang, B. L. Green Chem. 2012, 14, 2141.
(c) Bahrami, K.; Khodaei, M. M.; Naali, F. J. Org. Chem.
2008, 73, 6835. (d) Misra, R. S.; Barthwal, J. P.; Parmar, S.
S.; Singh, S. P.; Stenberg, V. I. J. Pharm. Sci. 1976, 65, 405.
(4) (a) Marsilje, T. H.; Hedrick, M. P.; Desharnais, J.; Tavassoli,
A.; Zhang, Y.; Wilson, I. A.; Benkovicd, S. J.; Boger, D. L.
Bioorg. Med. Chem. 2003, 11, 4487. (b) Tsutsumi, S.;
Okonogi, T.; Shibahara, S.; Ohuchi, S.; Hatsushiba, E.;
Patchett, A. A.; Christensen, B. G. J. Med. Chem. 1994, 37,
3492. (c) Meltzer-Mats, E.; Babai-Shani, G.; Pasternak, L.;
Urisky, N.; Getter, T.; Viskind, O.; Eckel, J.; Cerasi, E.;
Senderowitz, H.; Sasson, S.; Gruzman, A. J. Med. Chem.
2013, 56, 5335.
(5) Costanzo, M. J.; Yabut, S. C.; Almond, H. R. Jr.; Andrade-
Gordon, P.; Corcoran, T. W.; de Garavilla, L.; Kauffman, J.
A.; Abraham, W. M.; Recacha, R.; Chattopadhyay, D.;
Maryanoff, B. E. J. Med. Chem. 2003, 46, 3865.
(6) For recent paper of synthesis of 2-acylbenzothiazoles, see:
(a) Park, N.; Heo, Y.; Kumar, M. R.; Kim, Y.; Song, K. H.;
Lee, S. Eur. J. Org. Chem. 2012, 1984. (b) Sun, Y. D.; Jiang,
H. F.; Wu, W. Q.; Zeng, W.; Wu, X. Org. Lett. 2013, 15,
(13) To a Schlenk tube were added a mixture of β,β-dibromo-
styrene 1a (0.2 mmol) and 2,2′-disulfanediyldianiline 2a
(0.4 mmol), Cu(OTf)2 (10 mol%), Cs2CO3 (2 equiv), and
DMSO (2 mL). Then the mixture was stirred at 120 °C for
the indicated time until complete consumption of starting
material as monitored by TLC and GC–MS analysis. After
the reaction was finished, the mixture was washed with
brine. The aqueous phase was re-extracted with Et2O. The
combined organic extracts were dried over Na2SO4 and
concentrated under vacuum, and the resulting residue was
purified by silica gel column chromatography (hexane–
EtOAc) to afford the target product 3.
Benzo[d]thiazol-2-yl(4-methoxyphenyl)methanone (3):
white solid; mp 120–122 °C. 1H NMR (500 MHz, CDCl3): δ
= 8.58 (d, J = 9.0 Hz, 2 H), 8.17 (d, J = 8.0 Hz, 1 H), 7.94 (d,
J = 8.0 Hz, 1 H), 7.47–7.51 (m, 2 H), 6.98 (d, J = 9.0 Hz, 2
H), 3.85 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ = 183.4,
167.9, 164.4, 153.9, 136.9, 133.8, 127.8, 127.4, 126.8,
125.5, 122.1, 113.9, 55.6. LRMS (EI, 70 eV): m/z (%) = 269
(21) [M+], 241 (13), 135 (100), 107 (13), 92 (16), 77 (23).
Synlett 2014, 25, 255–260
© Georg Thieme Verlag Stuttgart · New York